Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis

J Cell Physiol
April 2018
https://pubmed.ncbi.nlm.nih.gov/28631829/

Recovery from Chronic Demyelination by Thyroid Hormone Therapy: Myelinogenesis Induction and Assessment by Diffusion Tensor Magnetic Resonance Imaging

J Neurosci
24 December 2008
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844750/

What Could Be a Primary Cause of Multiple Sclerosis: Is It an Autoimmunity Triggered by Chronic Protozoan Infection?

Journal of neuroinfectious diseases
2013
https://www.semanticscholar.org/paper/What-Could-Be-a-Primary-Cause-of-Multiple-Is-It-an-Simka/da3bebf4d4f100c49b4aad382a14781e268443be

Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis

J Microbiol Immunol Infect
August 2011
https://pubmed.ncbi.nlm.nih.gov/21524958/

Nematode filarial Worms in cerebrospinal fluid of a Multiple Sclerosis Patient at Autopsy

19 January 2016
https://f1000research.com/posters/5-79

Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI

Arq Neuropsiquiatr
September 2013
https://pubmed.ncbi.nlm.nih.gov/24141516/

Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial

Support Care Cancer
10 Jan 2022
https://pubmed.ncbi.nlm.nih.gov/35001215/

Paul Battle PA-C - Potential Applications for LDN (2013 Conference) (LDN, low dose naltrexone)

Friday afternoon Q & A (2017 Conference) (LDN, low dose naltrexone)

Questions on use of LDN in psoriasis, Lyme Disease, cancer, thyroid, diabetes, Crohn’s, MS, Lyme, vitiligo, other autoimmune diseases, administration route, dosing, nutrition, environmental toxins, LDN receptors, thymus proteins, peptides, stem cells, Vitamin D, insurance coverage for LDN, resources for testing and other treatments.